UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

Seven Direct Methods for Measuring HDL and LDL Cholesterol Compared with Ultracentrifugation Reference Measurement Procedures

Clinical chemistry (Baltimore, Md.), 2010-06, Vol.56 (6), p.977-986

2010

Link zum Volltext

Verfügbarkeit prüfen

Association Between High-Normal Levels of Alanine Aminotransferase and Risk Factors for Atherogenesis

Gastroenterology (New York, N.Y. 1943), 2013-12, Vol.145 (6), p.1271-1279.e3

2013

Link zum Volltext

Verfügbarkeit prüfen

Methods for Measurement of LDL-Cholesterol: A Critical Assessment of Direct Measurement by Homogeneous Assays versus Calculation

Clinical chemistry (Baltimore, Md.), 2002-02, Vol.48 (2), p.236-254

2002

Link zum Volltext

Verfügbarkeit prüfen

Comparative effects of an acute dose of fish oil on omega-3 fatty acid levels in red blood cells versus plasma: Implications for clinical utility

Journal of clinical lipidology, 2013-09, Vol.7 (5), p.433-440

2013

Link zum Volltext

Verfügbarkeit prüfen

Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement

Journal of clinical lipidology, 2011-07, Vol.5 (4), p.264-272

2011

Link zum Volltext

Verfügbarkeit prüfen

Non―HDL Cholesterol Shows Improved Accuracy for Cardiovascular Risk Score Classification Compared to Direct or Calculated LDL Cholesterol in a Dyslipidemic Population

Clinical chemistry (Baltimore, Md.), 2011-03, Vol.57 (3), p.490-501

2011

Link zum Volltext

Verfügbarkeit prüfen

Evolution of Methods for Measurement of HDL-Cholesterol: From Ultracentrifugation to Homogeneous Assays

Clinical chemistry (Baltimore, Md.), 2001-09, Vol.47 (9), p.1579-1596

2001

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a) mass: A massively misunderstood metric

Journal of clinical lipidology, 2014-11, Vol.8 (6), p.550-553

2014

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices

Clinical chemistry (Baltimore, Md.), 2009-03, Vol.55 (3), p.407-419

2009

Link zum Volltext

Verfügbarkeit prüfen

The correlation between TG vs remnant lipoproteins in the fasting and postprandial plasma of 23 volunteers

Clinica chimica acta, 2009-06, Vol.404 (2), p.124-127

2009

Link zum Volltext

Verfügbarkeit prüfen

Discordance between apolipoprotein B and low-density lipoprotein particle number is associated with insulin resistance in clinical practice

Journal of clinical lipidology, 2015-03, Vol.9 (2), p.247-255

2015

Link zum Volltext

Verfügbarkeit prüfen

Estimation of LDL-Associated Apolipoprotein B from Measurements of Triglycerides and Total Apolipoprotein B

Clinical chemistry (Baltimore, Md.), 2008-05, Vol.54 (5), p.907-910

2008

Link zum Volltext

Verfügbarkeit prüfen

Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices

Clinical chemistry (Baltimore, Md.), 2013-05, Vol.59 (5), p.752-770

2013

Link zum Volltext

Verfügbarkeit prüfen

Precision phenotyping, panomics, and system-level bioinformatics to delineate complex biologies of atherosclerosis: Rationale and design of the “Genetic Loci and the Burden of Atherosclerotic Lesions” study

Journal of cardiovascular computed tomography, 2014-11, Vol.8 (6), p.442-451

2014

Link zum Volltext

Verfügbarkeit prüfen

Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population

Journal of clinical lipidology, 2015-11, Vol.9 (6), p.817-823

2015

Link zum Volltext

Verfügbarkeit prüfen

A brief history of lipid and lipoprotein measurements and their contribution to clinical chemistry

Clinica chimica acta, 2006-07, Vol.369 (2), p.158-167

2006

Link zum Volltext

Verfügbarkeit prüfen

Fasting versus nonfasting triglycerides: implications for laboratory measurements

Clinical chemistry (Baltimore, Md.), 2008-01, Vol.54 (1), p.14-16

2008

Link zum Volltext

Verfügbarkeit prüfen

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group

Circulation (New York, N.Y.), 2004-12, Vol.110 (25), p.e545-e549

2004

Link zum Volltext

Verfügbarkeit prüfen

Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory

Clinical chemistry (Baltimore, Md.), 2002-01, Vol.48 (1), p.11-17

2002

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma

Clinical chemistry (Baltimore, Md.), 1998-12, Vol.44 (12), p.2490-2498

1998

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of four different equations for calculating LDL-C with eight different direct HDL-C assays

Clinica chimica acta, 2013-08, Vol.423, p.135-140

2013

Link zum Volltext

Verfügbarkeit prüfen

Validation of a lipoprotein(a) particle concentration assay by quantitative lipoprotein immunofixation electrophoresis

Clinica chimica acta, 2015-01, Vol.439, p.219-224

2015

Link zum Volltext

Verfügbarkeit prüfen

High-density lipoproteins: the neglected stepchildren whose importance as a risk factor continues to be defined

Clinical chemistry (Baltimore, Md.), 2008-05, Vol.54 (5), p.923-924

Warnick, G Russell

2008

Link zum Volltext

Verfügbarkeit prüfen

Assessment and Recommendations on Factors Contributing to Preanalytical Variability of Urinary Pyridinoline and Deoxypyridinoline

Clinical chemistry (Baltimore, Md.), 2002-02, Vol.48 (2), p.220-235

2002

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive Biomarker Testing of Glycemia, Insulin Resistance, and Beta Cell Function Has Greater Sensitivity to Detect Diabetes Risk Than Fasting Glucose and HbA1c and Is Associated with Improved Glycemic Control in Clinical Practice

Journal of cardiovascular translational research, 2014-08, Vol.7 (6), p.597-606

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(85)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(62)
Science & Technology
(55)
Life Sciences & Biomedicine
(53)
Female
(28)
Medical Laboratory Technology
(27)
Biological And Medical Sciences
(25)
Male
(23)
Adult
(22)
Triglycerides - Blood
(21)
Cholesterol
(20)
Medical Sciences
(20)
Middle Aged
(20)
Cholesterol - Blood
(19)
Cholesterol, Hdl - Blood
(17)
Aged
(16)
Cholesterol, Ldl - Blood
(16)
Investigative Techniques, Diagnostic Techniques
(15)
Lipoproteins
(14)
Lipoproteins - Blood
(14)
Methods
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Seven Direct Methods for Measuring HDL and LDL Cholesterol Compared with Ultracentrifugation Reference Measurement Procedures

Association Between High-Normal Levels of Alanine Aminotransferase and Risk Factors for Atherogenesis

Methods for Measurement of LDL-Cholesterol: A Critical Assessment of Direct Measurement by Homogeneous Assays versus Calculation

Comparative effects of an acute dose of fish oil on omega-3 fatty acid levels in red blood cells versus plasma: Implications for clinical utility

Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement

Non―HDL Cholesterol Shows Improved Accuracy for Cardiovascular Risk Score Classification Compared to Direct or Calculated LDL Cholesterol in a Dyslipidemic Population

Evolution of Methods for Measurement of HDL-Cholesterol: From Ultracentrifugation to Homogeneous Assays

Lipoprotein(a) mass: A massively misunderstood metric

Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices

The correlation between TG vs remnant lipoproteins in the fasting and postprandial plasma of 23 volunteers

Discordance between apolipoprotein B and low-density lipoprotein particle number is associated with insulin resistance in clinical practice

Estimation of LDL-Associated Apolipoprotein B from Measurements of Triglycerides and Total Apolipoprotein B

Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices

Precision phenotyping, panomics, and system-level bioinformatics to delineate complex biologies of atherosclerosis: Rationale and design of the “Genetic Loci and the Burden of Atherosclerotic Lesions” study

Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population

A brief history of lipid and lipoprotein measurements and their contribution to clinical chemistry

Fasting versus nonfasting triglycerides: implications for laboratory measurements

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group

Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory

Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma

Evaluation of four different equations for calculating LDL-C with eight different direct HDL-C assays

Validation of a lipoprotein(a) particle concentration assay by quantitative lipoprotein immunofixation electrophoresis

High-density lipoproteins: the neglected stepchildren whose importance as a risk factor continues to be defined

Assessment and Recommendations on Factors Contributing to Preanalytical Variability of Urinary Pyridinoline and Deoxypyridinoline

Comprehensive Biomarker Testing of Glycemia, Insulin Resistance, and Beta Cell Function Has Greater Sensitivity to Detect Diabetes Risk Than Fasting Glucose and HbA1c and Is Associated with Improved Glycemic Control in Clinical Practice

Suchergebnisse filtern